Although Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. (Janssen), recently settled two lawsuits over the antipsychotic drug Risperdal, they are still facing several thousand lawsuits. The pending cases in Philadelphia alone involve more than 2,000 plaintiffs.

As of January, the juries that have heard the cases have awarded a total of just over $74 million in damages against Janssen in four of the six trials, according to the Jere Beasley Report. Two other Risperdal cases have settled on the eve of trial. However, the drug makers say the recent settlements do not indicate plans to settle additional lawsuits in the future.

Plaintiffs contend Janssen concealed the risk of Risperdal’s most devastating side effect, gynecomastia, or the abnormal growth of breast tissue in young boys.

The drug went on the market in January 1994, shortly after the U.S. Food and Drug Administration (FDA) approved it for treating schizophrenia in adult patients. Four years later Janssen requested, but was denied, FDA approval of Risperdal dosing information for pediatric use.

Despite the fact that Risperdal was not approved for pediatric indications, Janssen aggressively marketed the drug for off-label uses in children and adolescents for the next nine years until it was ultimately approved for pediatric use, according to the Jere Beasley Report. In 2013, Johnson & Johnson agreed to a $2.2-billion settlement with the U.S. Department of Justice (DOJ) over these and other deceptive marketing practices involving Risperdal.

Risperdal-induced gynecomastia often requires invasive surgical procedures such as liposuction or mastectomy to remove the tissue. Righting Injustice explains that elevated levels of prolactin, the hormone that women produce while pregnant and just after childbirth to trigger lactation, is believed to cause gynecomastia.

Medical tests have revealed high levels of prolactin in patients taking Risperdal. Tender and painful breasts and nipple discharge often accompany the disfiguring condition, which also causes emotional and psychological problems.

* * *

If you or a loved one has suffered an injury as a result of taking Risperdal, contact James Lampkin, a lawyer in our firm’s Mass Torts Section, at 800-898-2034 or by email at

Jere Beasley Report (February 2017)
Righting Injustice
Jere Beasley Report (October 2012)

We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Risperdal Side Effects

Risperdal plaintiff granted retrial against J&J,...

Like thousands of other plaintiffs, W.C. alleges the defendants didn’t adequately warn about the risk...
Risperdal Side Effects

New York man awarded $1M in Risperdal gynecomastia...

Risperdal has been linked to a condition called gynecomastia, in which males grow female-like breasts....
Risperdal Side Effects

No new trial for Janssen Pharmaceutical in $2.5...

The company was seeking a new trial as part of an effort to overturn a $2.5 million jury verdict that...
Risperdal Side Effects

Risperdal legal troubles continue to mount

The suit was filed by a number of child advocacy organizations on behalf of children in the Missouri...
Beasley Allen New Principals Announced for 2015, David Dearing, Danielle Ward-Mason, Matt Teague and James Lampkin

Beasley Allen names Dearing, Mason, Teague and Lampkin...

Beasley Allen has named four attorneys as new Principals: David Dearing, James Lampkin, Danielle Ward...
Risperdal Side Effects

Risperdal side effects include breast development in...

Risperdal, also known as risperidone, has been linked to a condition known as gynecomastia,...

Best firm by far

Our case was handled with the utmost integrity and professionalism. If I could give them 10 stars, I would. This is the best legal firm I have ever dealt with by far.